ReviewCancer imaging : the official publication of the International Cancer Imaging Society2007
Post-treatment imaging of liver tumours.
Review in Cancer imaging : the official publication of the International Cancer Imaging Society, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 57 citations in OpenAlex.
- Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response.Cancer imaging : the official publication of the International Cancer Imaging Society · 2019Article
- Diagnostic performance of gadoxetic acid-enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection.BMC gastroenterology · 2019Article
- Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.Abdominal radiology (New York) · 2018Review
- Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update.Infectious agents and cancer · 2017Review
- Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE.European radiology · 2016Article
- Imaging Features of Radiofrequency Ablation with Heat-Deployed Liposomal Doxorubicin in Hepatic Tumors.Cardiovascular and interventional radiology · 2016Article
- Computed Tomography and Ultrasounds for the Follow-up of Hepatocellular Carcinoma Ablation: What You Need to Know.Diagnostics (Basel, Switzerland) · 2016Review
- Novel Imaging Diagnosis for Hepatocellular Carcinoma: Consensus from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).Liver cancer · 2015Article
- Non-invasive diagnostic imaging of colorectal liver metastases.World journal of radiology · 2015Review
- Article
- [Diagnosis of and therapy for hepatocellular carcinoma].Zeitschrift fur Gastroenterologie · 2013Article
- Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring.Cancer imaging : the official publication of the International Cancer Imaging Society · 2013Review
- Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer.World journal of radiology · 2011Article
- Morphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine.Hepatic medicine : evidence and research · 2010Review
- Dual energy CT: preliminary observations and potential clinical applications in the abdomen.European radiology · 2009Review
- The sonographer's role in RFA therapy of liver lesions.Biomedical imaging and intervention journal · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the past few years, great improvements have been made to achieve local tumour control of primary liver malignancies and liver metastases. For hepatocellular carcinoma (HCC), transarterial chemoembolisation (TACE) and tumour ablation techniques, including percutaneous ethanol injection (PEI), radiofrequency ablation (RF), and laser-induced interstitial thermotherapy (LITT) have been developed. For colorectal liver metastases, surgery is still the standard technique in localised disease, although percutaneous RF ablation has gained considerable acceptance. In patients with widespread disease, chemotherapy with new drugs offers improved survival. Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are the modalities of choice to evaluate treatment response. The present review demonstrates imaging findings of complete and incomplete tumour control after intervention as well as the imaging spectrum of complications. Imaging guidelines according to the World Health Organization and Response Evaluation Criteria In Solid Tumors (RECIST) for assessment of chemotherapy response are presented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.